Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2.
Aliyari SR, Ghaffari AA, Pernet O, Parvatiyar K, Wang Y, Gerami H, Tong AJ, Vergnes L, Takallou A, Zhang A, Wei X, Chilin LD, Wu Y, Semenkovich CF, Reue K, Smale ST, Lee B, Cheng G.
Aliyari SR, et al.
Acta Pharm Sin B. 2022 Apr;12(4):1624-1635. doi: 10.1016/j.apsb.2022.02.019. Epub 2022 Feb 28.
Acta Pharm Sin B. 2022.
PMID: 35251918
Free PMC article.